Mkts

Anixa Biosciences, Inc.

NASDAQ: ANIX
$2.99+0.21 (+7.55%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
2.743.14
52-week range
2.325.46
Today
Open2.80
Previous close2.99
Volume—
Valuation
Market cap103.94M
P/E ratio—
EPS (TTM)-0.31
Income & risk
Dividend / yield—
Beta0.47
Avg volume295.1K
Discussion

ANIX News

Stories mentioning ANIX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ2 '26Apr 30Q1 '26Jan 31Q4 '25Oct 31Q3 '25Jul 31Q2 '25Apr 30Q1 '25Jan 31Q4 '24Oct 31Q3 '24Jul 31
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.00
Operating Expenses
Research & Development1,2581,1021,1421,0551,3221,5521,4761,925
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(2,647)(2,716)(2,876)(2,436)(3,003)(3,386)(3,163)(3,592)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(2,516)(2,565)(2,695)(2,258)(2,790)(3,184)(2,883)(3,277)
Earnings Per Share (Basic)(0.07)(0.08)(84.22)(0.07)(0.09)(0.10)(90.09)(0.10)
Earnings Per Share (Diluted)(0.07)(0.08)(84.22)(0.07)(0.09)(0.10)(90.09)(0.10)
Weighted Average Shares Outstanding (Basic)33,59333,24032.0032,47632,20232,19732.0032,054
Weighted Average Shares Outstanding (Diluted)33,59333,24032.0032,47632,20232,19732.0032,054

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ANIX

Anixa Biosciences, Inc. (NASDAQ: ANIX) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANIX. It last traded at $2.99 (Oct 23, 2026, 4:00 PM ET), up 7.5% on the day. That gives Anixa Biosciences a market capitalisation of $103.9M.

Over the past 52 weeks ANIX has traded between $2.32 and $5.46.

For the quarter ended Apr 30, 2026 it reported a net loss of $2.5M.

Last 4 quarters
Quarter endedRevenueNet income
Apr 30, 2026—-$2.5M
Jan 31, 2026—-$2.6M
Oct 31, 2025—-$2.7M
Jul 31, 2025—-$2.3M

From Anixa Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…